Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 69,300 | -7,400 | 54,800 | 259,100 | 164,900 |
| Depreciation Amortization | 418,000 | 291,500 | 152,300 | 472,500 | 273,400 |
| Income taxes - deferred | -124,100 | -108,400 | -15,900 | -126,900 | -51,200 |
| Accounts receivable | 265,000 | 310,900 | 159,700 | -590,900 | -121,000 |
| Other Working Capital | -211,400 | -157,100 | -118,000 | -124,400 | -93,400 |
| Other Operating Activity | 29,200 | -29,400 | -132,500 | 742,600 | 237,500 |
| Operating Cash Flow | $446,000 | $300,100 | $100,400 | $632,000 | $410,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,500 | 8,700 | 2,500 | -7,500 | 3,900 |
| PPE Investments | -85,600 | -45,900 | -20,900 | -120,000 | -81,500 |
| Net Acquisitions | -383,500 | -383,500 | -384,100 | -575,100 | -571,600 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2,600 |
| Purchase Sale Intangibles | -5,900 | -3,600 | -1,800 | -18,700 | -17,700 |
| Other Investing Activity | -5,900 | -3,600 | -1,800 | -16,400 | -17,100 |
| Investing Cash Flow | $-471,500 | $-424,300 | $-404,300 | $-719,000 | $-668,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 375,000 | 375,000 | 375,000 | 400,000 | 400,000 |
| Debt Repayment | -201,700 | -125,300 | -60,000 | -428,800 | -303,800 |
| Common Stock Issued | 17,100 | 10,900 | 3,800 | 54,900 | 53,600 |
| Common Stock Repurchased | -15,400 | -13,700 | -11,400 | -14,200 | -13,600 |
| Other Financing Activity | -133,200 | -110,400 | -41,300 | 4,500 | 3,700 |
| Financing Cash Flow | $41,800 | $136,500 | $266,100 | $16,400 | $139,900 |
| Exchange Rate Effect | -3,600 | -4,000 | -2,800 | -2,900 | -700 |
| Beginning Cash Position | 209,300 | 209,300 | 209,300 | 282,800 | 282,800 |
| End Cash Position | 222,000 | 217,600 | 168,700 | 209,300 | 163,300 |
| Net Cash Flow | $12,700 | $8,300 | $-40,600 | $-73,500 | $-119,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 446,000 | 300,100 | 100,400 | 632,000 | 410,200 |
| Capital Expenditure | -93,300 | -53,300 | -22,800 | -126,700 | -87,900 |
| Free Cash Flow | 352,700 | 246,800 | 77,600 | 505,300 | 322,300 |